What is the NOAEL for Allyl phenylacetate?
Allyl phenylacetate has 19 NOAEL studies in the database. The lowest reported value is 0.48 % via Dermal in Human. Source: NTP_ICE_skin_sensitization.
Also known as: Benzeneacetic acid, 2-propenyl ester, Benzeneacetic acid, 2-propen-1-yl ester, 3-09-00-02181, Allyl alpha-toluate, BRN 1867491 (+7 more)
CAS 1797-74-6
Allyl phenylacetate (CAS 1797-74-6) is a chemical substance. Key regulatory status: 4 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS.
Allyl phenylacetate is classified GHS Danger (H301, H311, H302, H315, H317, H319) in the chemicals database but is restricted in EU cosmetics.
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| IFRA Transparency | IFRA | IFRA |
| Europe | European Commission | Fl@vis |
| food_additive; Substances Added to Food (formerly EAFUS) (2/2019) | FDA | United States Food and Drug Administration (FDA) |
| Europe; Personal care; restricted | European Commission | CosIng |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 0.6 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 1.25 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 0.48 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 1 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 3D2NBC7K7Q | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 3D2NBC7K7Q | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 3D2NBC7K7Q | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 3D2NBC7K7Q | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| - | % | Incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 48 | % | Incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 100 | % | Incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 2025 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP_ICE_skin_sensitization |
| 8100 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP_ICE_skin_sensitization |
| 405 | ug/cm2 | Induction dose per skin area, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 843.75 | ug/cm2 | Induction dose per skin area, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 324 | ug/cm2 | Induction dose per skin area, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 675 | ug/cm2 | Induction dose per skin area, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| =650 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
| 3 | unitless | Relative reliability score | Dermal | Human | NTP_ICE_skin_sensitization |
Showing 19 of 19 studies
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS cannabis compliance and lab records where available.
1 cannabis record found in efsa substances.
View full cannabis profile →Allyl phenylacetate has 19 NOAEL studies in the database. The lowest reported value is 0.48 % via Dermal in Human. Source: NTP_ICE_skin_sensitization.
Allyl phenylacetate appears on 4 regulatory/inventory lists including IFRA Transparency, Europe, food_additive; Substances Added to Food (formerly EAFUS) (2/2019), and 1 more. Source: EPA CPDat.
Yes, Allyl phenylacetate is also indexed as a cosmetic ingredient under the name Allyl Phenylacetate. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, CosIng / Ingredients DB, cannabis regulatory/lab databases. All data traces to primary regulatory sources and is updated from official government databases.
Allyl phenylacetate is classified GHS Danger (H301, H311, H302, H315, H317, H319) in the chemicals database but is restricted in EU cosmetics.
Allyl phenylacetate also appears in cosmetics, cannabis databases.